A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects
Clinical trial NCT06964230 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06964230
- Sponsor
- T3D Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-26
- Primary completion
- 2031-04-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.